JP2005047851A5 - - Google Patents

Download PDF

Info

Publication number
JP2005047851A5
JP2005047851A5 JP2003281590A JP2003281590A JP2005047851A5 JP 2005047851 A5 JP2005047851 A5 JP 2005047851A5 JP 2003281590 A JP2003281590 A JP 2003281590A JP 2003281590 A JP2003281590 A JP 2003281590A JP 2005047851 A5 JP2005047851 A5 JP 2005047851A5
Authority
JP
Japan
Prior art keywords
coenzyme
ubidecarenone
effective
heart failure
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003281590A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005047851A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2003281590A priority Critical patent/JP2005047851A/ja
Priority claimed from JP2003281590A external-priority patent/JP2005047851A/ja
Publication of JP2005047851A publication Critical patent/JP2005047851A/ja
Publication of JP2005047851A5 publication Critical patent/JP2005047851A5/ja
Pending legal-status Critical Current

Links

JP2003281590A 2003-07-29 2003-07-29 ユビデカレノン含有組成物 Pending JP2005047851A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003281590A JP2005047851A (ja) 2003-07-29 2003-07-29 ユビデカレノン含有組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003281590A JP2005047851A (ja) 2003-07-29 2003-07-29 ユビデカレノン含有組成物

Publications (2)

Publication Number Publication Date
JP2005047851A JP2005047851A (ja) 2005-02-24
JP2005047851A5 true JP2005047851A5 (https=) 2006-04-20

Family

ID=34267044

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003281590A Pending JP2005047851A (ja) 2003-07-29 2003-07-29 ユビデカレノン含有組成物

Country Status (1)

Country Link
JP (1) JP2005047851A (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4970734B2 (ja) * 2005-03-03 2012-07-11 株式会社コーセー 透明水性組成物
JP2007074937A (ja) * 2005-09-12 2007-03-29 Marubeni Nisshin Feed Co Ltd コエンザイムq10強化卵及びその生産方法並びに家禽用配合飼料
JP4799102B2 (ja) * 2005-09-26 2011-10-26 日清オイリオグループ株式会社 油性皮膚用組成物
US8574568B2 (en) 2005-11-07 2013-11-05 Kaneka Corporation Reduced coenzyme Q10-containing composition comprising a surfactant which is stable against oxidation and method for stabilization by mixing with surfactant(s)
JP2007181408A (ja) * 2005-12-31 2007-07-19 Nippon Same No Kai Bussan Kk スクアレン加工食品
JP4644135B2 (ja) * 2006-02-09 2011-03-02 太陽化学株式会社 コエンザイムq10含有組成物
JP2008005813A (ja) * 2006-06-30 2008-01-17 Ezaki Glico Co Ltd コエンザイムq10含有チョコレート
WO2013121906A1 (ja) * 2012-02-15 2013-08-22 日清オイリオグループ株式会社 飼料用組成物、飼料、及び飼料の製造方法
WO2017199223A1 (en) * 2016-05-20 2017-11-23 Nestec Sa Nutritional compositions for cardciac protection in companion animals

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5581813A (en) * 1978-12-16 1980-06-20 Nisshin Flour Milling Co Ltd Composition containing coenzyme q10 and its perparation
JP3487881B2 (ja) * 1993-09-30 2004-01-19 太陽化学株式会社 界面活性剤
DE19509354A1 (de) * 1994-12-08 1996-06-13 Klett Loch Lore M Kombinationspräparat zur Förderung des Haarwachstums und ggf. des Haut- und Nagelwachstums sowie zur Verhinderung bzw. zur Beseitigung von Haarausfall
WO1996036316A1 (en) * 1995-05-19 1996-11-21 Abbott Laboratories Self-emulsifying formulations of lipophilic drugs
GB9608719D0 (en) * 1996-04-26 1996-07-03 Scherer Ltd R P Pharmaceutical compositions
JP3533605B2 (ja) * 2001-12-06 2004-05-31 すこやか食品株式会社 血圧降下、心臓強化、動脈硬化防止、血管保護、抗疲労、運動機能向上、エネルギー代謝効率向上、抗酸化などの諸効果を有する栄養補助食品。

Similar Documents

Publication Publication Date Title
JP2003520232A5 (https=)
CY1119148T1 (el) Φαρμακευτικες συνθεσεις και συναφεις μεθοδοι χορηγησης
EA200701175A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
CY1116747T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
JP2010505817A5 (https=)
EA200400881A1 (ru) Азаарилпиперазины
CY1105127T1 (el) Συνθεση για την προληψη καρδιαγγειακων νοσων
RU2350333C3 (ru) Применение ивермектина для лечения дерматологических расстройств
CY1115719T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
NO20050896L (no) Probiotika for neuromuskulaere funksjoner i tarmen
JP2003526622A5 (https=)
Klein et al. Thyroid (neuro) myopathy.
JP2005047851A5 (https=)
WO2009058005A3 (en) Unit dosage for brain health
EP1852114A4 (en) COMPOSITION WITH DIHOMO (GAMMA) LINE ACIDIC ACID (DGLA) AS AN ACTIVE INGREDIENTS
JP2005511748A5 (https=)
ATE543491T1 (de) Kombinationspräparat enthaltend ibuprofen und paracetamol
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
ATE432921T1 (de) Quadratsäurederivate mit antiproliferativer wirkung
RU2006109966A (ru) Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных
RU2005132163A (ru) 2-(бутил-1-сульфониламино)-n-[1(r)-(6-метоксипиридин-3-ил)-пропил]бензамид, его применение в качестве лекарственного средства, а также содержащие его фармацевтические композиции
RU2004109902A (ru) Лечебный корм для рыб
JP2007326799A5 (https=)
RU2003108517A (ru) Способ лечения колибактериоза и сальмонеллеза у поросят
Aukerman Do vitamin C supplements reduce cardiovascular disease mortality?